Dr Agarwal’s Health Care merger vote: 100% nod in 2026

Unsecured creditors clear a key step

Dr Agarwal's Health Care Limited (AHCL) has received unanimous approval from its unsecured creditors for its proposed Scheme of Amalgamation with Dr Agarwal's Eye Hospital Limited (AEHL). The vote was held at a creditor meeting on July 02, 2026.

The resolution received 100% support, with 11,10,20,428 votes cast in favour and none against. The company described this as an important procedural step that helps move the merger process forward. The amalgamation, however, remains subject to final sanction from the National Company Law Tribunal (NCLT).

What was voted on, and why it matters

The meeting was convened specifically for unsecured creditors to consider and approve the Scheme of Amalgamation between AHCL and AEHL. Approval by creditors is one of the key stakeholder clearances required in court-driven merger processes in India.

With unsecured creditors backing the proposal unanimously, AHCL has met a major requirement to proceed with the scheme. The development reduces the risk of objections from this stakeholder group at later stages. The company can now progress to the next procedural and regulatory steps, including seeking the final NCLT sanction.

Voting outcome: 100% in favour

As per the disclosed results, 32 unsecured creditor members participated in the voting process. All votes were in favour of the resolution.

The Scrutinizer consolidated voting outcomes across remote e-voting, e-voting at the meeting venue, and polling papers. The resolution was approved by the requisite special majority of unsecured creditors.

Breakdown of how creditors voted

The voting was conducted across three channels and then consolidated into a final outcome.

What changes operationally after this vote

The unsecured creditors’ approval is a procedural milestone, not the final closure of the merger. It enables AHCL’s board to proceed with implementing the approved scheme and to address matters incidental to the amalgamation process.

The company is now awaiting the final sanction from the NCLT to complete the merger. Until that approval is received, the amalgamation is not considered consummated.

NCLT’s role and the earlier direction to convene meetings

The NCLT, Chennai Bench, had earlier approved the convening of meetings for AEHL and AHCL shareholders and creditors to vote on the scheme. The NCLT order was pronounced on May 05, 2026, and uploaded on May 11, 2026.

AHCL had also disclosed that the NCLT’s order dated May 05, 2026 directed stakeholder meetings on July 02, 2026 to consider the proposed amalgamation. The company noted that the scheme is subject to necessary statutory and regulatory approvals.

AEHL shareholder vote and the proposed share swap

Separately, AEHL shareholders were scheduled to vote on the amalgamation with AHCL on July 02, 2026. The NCLT had directed a meeting of AEHL shareholders for this purpose, scheduled at The Music Academy, Chennai.

If approved, AEHL will merge into AHCL. Under the stated share exchange ratio, eligible AEHL shareholders would receive 23 equity shares of AHCL for every 2 equity shares held in AEHL, based on a valuation report. The voting process included remote e-voting from June 07, 2026 to July 01, 2026, along with in-person voting at the meeting.

Stock exchange observations and compliance conditions

The amalgamation process has also involved review by stock exchanges. AEHL secured BSE approval for the amalgamation scheme, with “no adverse observations” dated February 17, 2026. This approval was accompanied by 17 specific SEBI compliance conditions and required submission to the NCLT within six months.

AHCL also disclosed that it received “no adverse observations” from BSE Limited and a “no objection” letter from the National Stock Exchange of India (NSE), dated February 16-17, 2026. These are positioned as key milestones but not substitutes for NCLT approval and stakeholder votes.

Timeline of key disclosed milestones

The sequence below captures the key dated steps described across the merger process.

Market impact and what investors track next

The reported “Reader Takeaway” is that unanimous creditor approval reduces merger execution risk, with final NCLT sanction identified as the next key hurdle. From a process standpoint, the unsecured creditors’ vote reduces the likelihood of delays due to this stakeholder group’s objections.

For investors and stakeholders, the immediate focus remains on completion steps that are explicitly stated as pending, including the NCLT’s final sanction and other necessary statutory and regulatory approvals. The merger also includes a defined share exchange ratio for AEHL shareholders, which remains central to how the consolidation would be implemented if all approvals are obtained.

Conclusion

AHCL’s unsecured creditors have unanimously approved the Scheme of Amalgamation with AEHL at the July 02, 2026 meeting, with 32 participating members casting 11,10,20,428 votes in favour and none against. The Scrutinizer consolidated results across multiple voting modes, and the resolution passed with the requisite special majority.

The amalgamation process now awaits the final NCLT sanction, which is the next procedural step explicitly identified as pending in the disclosures around the transaction.